GLP-1 medications have transformed the treatment of diabetes and obesity, but scientists are still uncovering exactly how they work. In this UConn Health Minute segment, researcher Samantha Fortin, PhD, explains how her lab is focusing on how these drugs affect the brain and how they can be improved for the future.
Samantha Fortin, PhD, in her lab discussing GLP-1 research with graduate student Abby Bendixen. Fortin is an assistant professor in the Departments of Medicine and Neuroscience. (Ryan Bernat/UConn Health)
GLP-1 medications have transformed the treatment of diabetes and obesity, but scientists are still uncovering exactly how they work. In this UConn Health Minute segment, researcher Samantha Fortin, PhD, explains how her lab is focusing on how these drugs affect the brain and how they can be improved for the future.
